EDGAR Filing Documents for 0001654954-19-012832

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-19-012832

Filing Date

2019-11-13

Accepted

2019-11-13 14:54:51

Documents

Period of Report

2019-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	sbfm_10q.htm	10-Q	695325
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex311.htm	EX-31.1	12996
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex312.htm	EX-31.2	12699
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	sbfm_ex32.htm	EX-32	8626
5	IMAGE	fig1.jpg	GRAPHIC	9791
6	IMAGE	fig2.jpg	GRAPHIC	21662
7	IMAGE	fig4.jpg	GRAPHIC	13284
8	IMAGE	fig5.jpg	GRAPHIC	13314
9	IMAGE	sbfm_10q002.jpg	GRAPHIC	15161
	Complete submission text file	0001654954-19-012832.txt		2156294

Data Files

Seq	Description	Document	Type	Size
10	XBRL INSTANCE DOCUMENT	sbfm-20190930.xml	EX-101.INS	255058
11	XBRL TAXONOMY EXTENSION SCHEMA	sbfm-20190930.xsd	EX-101.SCH	17058
12	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	sbfm-20190930_cal.xml	EX-101.CAL	41840
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	sbfm-20190930_def.xml	EX-101.DEF	41439
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sbfm-20190930_lab.xml	EX-101.LAB	143744
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sbfm-20190930_pre.xml	EX-101.PRE	109869

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)